Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Press Releases
Sort By
Newest First
1 / 152
1 / 152
Clinical Trials
GenBio AI Releases Phase 1 of World's First Digital Organism to Transform Medical Research
GenBio AI
PR-12-24-NI-144
Dec 19, 2024
Announcement
CellFE® Announces Strategic Placements with Leading Pharma and Biotech Companies
CellFE
PR-12-24-NI-143
Dec 19, 2024
Announcement
Inceptor Bio and GRIT Bio Cooperate to Advance IB-T101, a Next-Generation Solid Tumor CAR-T Utilizing the OUTLAST™ Platform
Inceptor Bio
PR-12-24-NI-142
Dec 18, 2024
Investment
Samsung invests in Generate: Biomedicines to advance AI-driven protein therapeutics discovery
Samsung Biologics
PR-12-24-NI-141
Dec 18, 2024
H5 Bird Flu Test
Labcorp Launches H5 Bird Flu Test in the U.S., Now Available for Order through Physicians
LabCorp
PR-12-24-NI-140
Dec 17, 2024
Bioelectronic
Ginkgo, Carnegie Mellon get $9.4M from ARPA-H to develop implantable bioelectronic devices for disease treatment.
Ginkgo Bioworks
PR-12-24-NI-139
Dec 17, 2024
sustainability
Samsung Biologics listed among top most sustainable companies in Dow Jones Sustainability World Index
Samsung Biologics
PR-12-24-NI-138
Dec 17, 2024
Announcement
Theravance Biopharma to Conduct Investor Meetings During the J.P. Morgan 43rd Annual Healthcare Conference
Theravance Biopharma
PR-12-24-NI-137
Dec 17, 2024
Announcement
Karyopharm Announces the Appointment of Brendan Strong as Senior Vice President of Investor Relations and Corporate Communications
Karyopharm Therapeutics Inc.
PR-12-24-NI-135
Dec 12, 2024
Announcement
Porton Pharma Solutions and Aojin Life Sciences Strategically Collaborate to Advance XDC Conjugate Drugs for Dual IND Filings
Porton Pharma Solutions
PR-12-24-NI-136
Dec 12, 2024
Sustainability
Olon Releases its Annual ESG Report
Olon
PR-11-24-NI-110
Dec 12, 2024
Announcement
AbbVie Announces Topline Results for the Phase 3 TEMPO-2 Trial Evaluating Tavapadon as a Monotherapy for Parkinson's Disease
AbbVie
PR-12-24-NI-134
Dec 11, 2024
Announcementan
Biolexis Therapeutics Announces Positive Results from Expanded Diet Induced Obesity (DIO) Model Study for BLX-7006
Biolexis Therapeutics Inc
PR-12-24-NI-133
Dec 10, 2024
Announcement
Carisma Therapeutics Announces Strategic Restructuring to Re-prioritize Pipeline
Carisma Therapeutics Inc.
PR-12-24-NI-132
Dec 10, 2024
Clinical Trials
Beacon Therapeutics Announces Positive 3-Month Data from Phase 2 DAWN Trial in Patients
Beacon Therapeutics
PR-12-24-NI-131
Dec 06, 2024
Announcement
Amgen Announces $1 Billion Manufacturing Expansion in North Carolina
Amgen
PR-12-24-NI-129
Dec 06, 2024
Executive
ProBio Announces New Executive Appointments
ProBio Inc
PR-12-24-NI-128
Dec 05, 2024
Decarbonization
Samsung Biologics Hosts ESG Event with Suppliers to Strengthen Decarbonization Efforts
Samsung Biologics
PR-12-24-NI-127
Dec 03, 2024
Pediatric
Johnson & Johnson Seeks U.S. FDA Approval for First Pediatric Indications for TREMFYA®
Johnson & Johnson
PR-12-24-NI-126
Dec 03, 2024
Antibody
Spyre Therapeutics Announces First Participants Dosed in Phase 1 Trials of Novel Half-life Extended Anti-TL1A Antibodies
Spyre Therapeutics, Inc.
PR-12-24-NI-125
Dec 03, 2024
